DrugJan 7, 2026
Novo Nordisk Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens recall — FDA D-0245-2026
Presence of Particulate Matter: Hair was found in a prefilled syringe
Class IIFDA: OngoingNovo Nordisk Inc.
Recall history in this database
Classification mix: Class I: 10, Class II: 6.
DrugJan 7, 2026
Novo Nordisk Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens recall — FDA D-0244-2026
Presence of Particulate Matter: Hair was found in a prefilled syringe
Class IIFDA: OngoingNovo Nordisk Inc.
DrugApr 21, 2021
Saxenda (liraglutide) Injection, 18 mg/3 mL (6 mg/mL), 1 x 3 mL Prefilled Pen, Sample recall — FDA D-0618-2021
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the…
Class IIFDA: TerminatedNovo Nordisk Inc.
DrugApr 21, 2021
INSULIN DILUTING MEDIUM FOR NOVOLOG NovoLog FlexPen (insulin aspart) Injection, 100 recall — FDA D-0615-2021
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the…
Class IFDA: TerminatedNovo Nordisk Inc.
DrugApr 21, 2021
Novo Nordisk OZEMPIC (semaglutide) injection, 2 mg/1.5 mL (1.34 mg/mL) Prefilled pen, 1 pen recall — FDA D-0617-2021
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the…
Class IIFDA: TerminatedNovo Nordisk Inc.
DrugApr 21, 2021
ViCTOZA (liraglutide) injection, 18 mg/3 mL (6 mg/mL), contains: 1 Victoza Pen, Sample Not recall — FDA D-0622-2021
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the…
Class IIFDA: TerminatedNovo Nordisk Inc.
DrugApr 21, 2021
TRESIBA recall — FDA D-0620-2021
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the…
Class IFDA: TerminatedNovo Nordisk Inc.
DrugApr 21, 2021
Fiasp PenFill (insulin aspart injection) 100 units/mL (U-100), 3 mL cartridge, 5 cartridges recall — FDA D-0612-2021
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the…
Class IFDA: TerminatedNovo Nordisk Inc.
DrugApr 21, 2021
Xultophy 100/3.6 recall — FDA D-0623-2021
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the…
Class IFDA: TerminatedNovo Nordisk Inc.
DrugApr 21, 2021
Levemir FlexTouch (insulin detemir) injection, 100 units/mL (U-100), 3 mL Prefilled Pen recall — FDA D-0614-2021
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the…
Class IFDA: TerminatedNovo Nordisk Inc.
DrugApr 21, 2021
Fiasp (insulin aspart injection), 100 units/mL (U-100), One 10 mL multi-dose vial, Sample recall — FDA D-0613-2021
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the…
Class IFDA: TerminatedNovo Nordisk Inc.
DrugApr 21, 2021
Fiasp FlexTouch (insulin aspart injection) 100 units/mL (U-100), 3 mL Prefilled Pen, Sample recall — FDA D-0611-2021
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the…
Class IFDA: TerminatedNovo Nordisk Inc.
DrugApr 21, 2021
TRESIBA FlexTouch recall — FDA D-0619-2021
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the…
Class IFDA: TerminatedNovo Nordisk Inc.
DrugApr 21, 2021
INSULIN DILUTING MEDIUM FOR NOVOLOG NovoLog (Insulin aspart) Injection, 100 units/mL recall — FDA D-0616-2021
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the…
Class IFDA: TerminatedNovo Nordisk Inc.
DrugApr 21, 2021
TRESIBA FlexTouch recall — FDA D-0621-2021
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the…
Class IFDA: TerminatedNovo Nordisk Inc.
DrugJun 15, 2016
Norditropin FlexPro Somatropin (rDNA origin) injection, 30 mg/3 mL Prefilled Pen recall — FDA D-0956-2016
Defective Delivery System; may have a low frequency assembly fault which may result in pens block during the so-called "air shot" step
Class IIFDA: TerminatedNovo Nordisk Inc.
Understanding this recall history
This page summarizes recall records in which the official source identifies Novo Nordisk Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.